Global and Japan Exosomes Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Exosomes Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Non-coding RNAs
  • 1.2.3 Lipids
  • 1.2.4 mRNA
  • 1.2.5 DNA fragments
  • 1.2.6 Proteins /peptides
• 1.3 Market by Application
  • 1.3.1 Global Exosomes Market Share by Application: 2020 VS 2026
  • 1.3.2 Cancer
  • 1.3.3 Infectious diseases
  • 1.3.4 Neurodegenerative diseases
  • 1.3.5 Cardiovascular diseases
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Exosomes Market Perspective (2015-2026)
• 2.2 Global Exosomes Growth Trends by Regions
  • 2.2.1 Exosomes Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Exosomes Historic Market Share by Regions (2015-2020)
  • 2.2.3 Exosomes Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Exosomes Players by Market Size
  • 3.1.1 Global Top Exosomes Players by Revenue (2015-2020)
  • 3.1.2 Global Exosomes Revenue Market Share by Players (2015-2020)
• 3.2 Global Exosomes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Exosomes Revenue
• 3.4 Global Exosomes Market Concentration Ratio
  • 3.4.1 Global Exosomes Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Exosomes Revenue in 2019
• 3.5 Key Players Exosomes Area Served
• 3.6 Key Players Exosomes Product Solution and Service
• 3.7 Date of Enter into Exosomes Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Exosomes Breakdown Data by Type (2015-2026)

• 4.1 Global Exosomes Historic Market Size by Type (2015-2020)
• 4.2 Global Exosomes Forecasted Market Size by Type (2021-2026)

5 Exosomes Breakdown Data by Application (2015-2026)

• 5.1 Global Exosomes Historic Market Size by Application (2015-2020)
• 5.2 Global Exosomes Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Exosomes Market Size (2015-2026)
• 6.2 North America Exosomes Market Size by Type (2015-2020)
• 6.3 North America Exosomes Market Size by Application (2015-2020)
• 6.4 North America Exosomes Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Exosomes Market Size (2015-2026)
• 7.2 Europe Exosomes Market Size by Type (2015-2020)
• 7.3 Europe Exosomes Market Size by Application (2015-2020)
• 7.4 Europe Exosomes Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Exosomes Market Size (2015-2026)
• 8.2 China Exosomes Market Size by Type (2015-2020)
• 8.3 China Exosomes Market Size by Application (2015-2020)
• 8.4 China Exosomes Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Exosomes Market Size (2015-2026)
• 9.2 Japan Exosomes Market Size by Type (2015-2020)
• 9.3 Japan Exosomes Market Size by Application (2015-2020)
• 9.4 Japan Exosomes Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Exosomes Market Size (2015-2026)
• 10.2 Southeast Asia Exosomes Market Size by Type (2015-2020)
• 10.3 Southeast Asia Exosomes Market Size by Application (2015-2020)
• 10.4 Southeast Asia Exosomes Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

• 11.1 Fujifilm
  • 11.1.1 Fujifilm Company Details
  • 11.1.2 Fujifilm Business Overview
  • 11.1.3 Fujifilm Exosomes Introduction
  • 11.1.4 Fujifilm Revenue in Exosomes Business (2015-2020))
  • 11.1.5 Fujifilm Recent Development
• 11.2 Thermo Fisher Scientific
  • 11.2.1 Thermo Fisher Scientific Company Details
  • 11.2.2 Thermo Fisher Scientific Business Overview
  • 11.2.3 Thermo Fisher Scientific Exosomes Introduction
  • 11.2.4 Thermo Fisher Scientific Revenue in Exosomes Business (2015-2020)
  • 11.2.5 Thermo Fisher Scientific Recent Development
• 11.3 Danaher
  • 11.3.1 Danaher Company Details
  • 11.3.2 Danaher Business Overview
  • 11.3.3 Danaher Exosomes Introduction
  • 11.3.4 Danaher Revenue in Exosomes Business (2015-2020)
  • 11.3.5 Danaher Recent Development
• 11.4 Illumina
  • 11.4.1 Illumina Company Details
  • 11.4.2 Illumina Business Overview
  • 11.4.3 Illumina Exosomes Introduction
  • 11.4.4 Illumina Revenue in Exosomes Business (2015-2020)
  • 11.4.5 Illumina Recent Development
• 11.5 Qiagen
  • 11.5.1 Qiagen Company Details
  • 11.5.2 Qiagen Business Overview
  • 11.5.3 Qiagen Exosomes Introduction
  • 11.5.4 Qiagen Revenue in Exosomes Business (2015-2020)
  • 11.5.5 Qiagen Recent Development
• 11.6 Takara Bio
  • 11.6.1 Takara Bio Company Details
  • 11.6.2 Takara Bio Business Overview
  • 11.6.3 Takara Bio Exosomes Introduction
  • 11.6.4 Takara Bio Revenue in Exosomes Business (2015-2020)
  • 11.6.5 Takara Bio Recent Development
• 11.7 Malvern Instruments
  • 11.7.1 Malvern Instruments Company Details
  • 11.7.2 Malvern Instruments Business Overview
  • 11.7.3 Malvern Instruments Exosomes Introduction
  • 11.7.4 Malvern Instruments Revenue in Exosomes Business (2015-2020)
  • 11.7.5 Malvern Instruments Recent Development
• 11.8 Miltenyi Biotec
  • 11.8.1 Miltenyi Biotec Company Details
  • 11.8.2 Miltenyi Biotec Business Overview
  • 11.8.3 Miltenyi Biotec Exosomes Introduction
  • 11.8.4 Miltenyi Biotec Revenue in Exosomes Business (2015-2020)
  • 11.8.5 Miltenyi Biotec Recent Development
• 11.9 MBL International
  • 11.9.1 MBL International Company Details
  • 11.9.2 MBL International Business Overview
  • 11.9.3 MBL International Exosomes Introduction
  • 11.9.4 MBL International Revenue in Exosomes Business (2015-2020)
  • 11.9.5 MBL International Recent Development
• 11.10 Lonza
  • 11.10.1 Lonza Company Details
  • 11.10.2 Lonza Business Overview
  • 11.10.3 Lonza Exosomes Introduction
  • 11.10.4 Lonza Revenue in Exosomes Business (2015-2020)
  • 11.10.5 Lonza Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer